Clinical Scorecard: Antibody Oxidation’s Hidden Handedness Comes Into View

At a Glance

Key Highlights

• New analytical strategy reveals stereoisomers of methionine sulfoxide in antibodies
• Focus on Met252 and Met428 in IgG1 antibodies
• Oxidation alters receptor binding and stability
• NMR and LC-MS techniques provide atomic resolution insights
• Enhanced stability testing and manufacturing control for antibody drugs

Guideline-Based Recommendations

Diagnosis

• Utilize NMR spectroscopy and LC-MS for detailed analysis of antibody oxidation

Management

• Implement selective enzymatic reduction to assess stereochemical diversity

Monitoring & Follow-up

• Regularly evaluate oxidation levels of methionine residues in therapeutic antibodies

Risks

• Potential alterations in receptor binding and in vivo persistence due to oxidation

Patient & Prescribing Data

Individuals receiving monoclonal antibody therapies

Understanding methionine oxidation can improve therapeutic efficacy and safety

Clinical Best Practices

• Incorporate advanced analytical techniques in antibody drug development
• Monitor oxidation states to ensure therapeutic stability
• Enhance manufacturing controls based on oxidation profiles

References

• National Institutes of Natural Sciences Research